C5 Biomedical's Tim Maye Honored Among 50 Influential Leaders at AATB Anniversary

Celebrating Tim Maye: A Visionary in Tissue Banking

In a remarkable evening in San Francisco, Tim Maye, Chief Executive Officer of C5 Biomedical LLC, received a prestigious accolade from the Association for Advancing Tissue and Biologics (AATB). This honor, titled “50 at 50,” recognizes individuals who have significantly influenced the AATB over its 50-year history. Maye's achievement is particularly notable as it coincides with AATB's 50th Anniversary Celebration, signifying not only personal success but also the transformative impact he has had on the field of tissue banking.

Tim Maye's Journey in Tissue Banking

With nearly three decades of experience, Tim Maye stands out as a leader in the tissue banking and biologics sector. He has held the Certified Tissue Bank Specialist (CTBS) credential since 1999 and demonstrated his commitment and expertise by chairing AATB's Standards Committee for six years. In 2021, he founded C5 Biomedical, a company that has quickly established itself in the realm of amniotic membrane allografts, achieving AATB accreditation in November 2025 through standards that he contributed to creating.

Reflecting on his recognition, Maye expressed gratitude towards his peers: "This recognition belongs to my colleagues who have tirelessly worked to enhance standards in tissue banking over the years. I have had the privilege of helping to draft some of the crucial standards that guide our industry today, and I am excited to continue my work on the committee. There is still more to be done." His words resonate with a commitment to ongoing improvement and innovation in the field.

The Importance of Standards in Tissue Banking

As chair of the AATB Standards Committee, Tim Maye was pivotal in ensuring the establishment and refinement of safety and quality standards in tissue banking. Beverly Bliss, MBA, CTBS, the former AATB Vice President of Accreditation and Standards, praised Maye’s leadership during his tenure. “Tim brought a sense of unity and calm to the committee, allowing its members to engage in open discussions and debates, ultimately achieving the best outcomes for the industry.” His efforts have been instrumental in shaping the current protocols, setting a high bar for quality in tissue banking practices.

C5 Biomedical’s Role in Innovation

C5 Biomedical is noted for its commitment to creating high-quality amniotic membrane allografts, which serve an array of surgical applications, including wound care, burns, ocular conditions, and more. Its product lines, such as AéroGuard™, NéoGuard™, xPatch™, and iPatch™, are recognized for their efficacy and safety. Additionally, the company offers private-label allografts to various distributors, further extending its influence within the industry. Under Maye’s stewardship, C5 Biomedical exemplifies innovation and dedication to quality in tissue banking, reinforcing the importance of adherence to established standards.

Looking Ahead: Continued Commitment to Excellence

As the AATB Congress 26 unfolds, attendees will celebrate not only the past but also the future of tissue banking. The full list of honorees, comprising industry stalwarts like Maye, is available on the AATB's official website. With recognition comes responsibility, and Tim Maye’s continued involvement in the AATB’s Standards Committee signifies his ongoing dedication to elevating standards within the sector.

In conclusion, Tim Maye’s accolade is a testament to his dedication and profound influence on the tissue and biologics field. As he continues to champion safety and quality, the future of tissue banking looks promising, shaped by the contributions of leaders like him.

For more information about C5 Biomedical and its innovative products, visit their website or reach out directly.

C5 Biomedical Contact:
Stephen Maye
Chief Revenue Officer
C5 Biomedical LLC
Email: [email protected]
Phone: 703-371-8392

AATB Official Website:
www.aatb.org